Medisca to pay $21.75 million to settle case alleging false and inflated ingredient prices, accused of inflating prices for resveratrol and mometasone furoate.
The Alliance for Pharmacy Compounding, which represents compounding pharmacists and technicians, said in its statement that Novo was "confusing the fact that the semaglutide molecule is ...
The Alliance for Pharmacy Compounding was quick to note that adverse events reported by patients taking compounded versions of the drug “are remarkably similar to those reported by patients ...